Concentrix (NASDAQ:CNXC) Shares Down 6.1% – Time to Sell?
by Renee Jackson · The Cerbat GemShares of Concentrix Corporation (NASDAQ:CNXC – Get Free Report) dropped 6.1% during mid-day trading on Monday . The company traded as low as $41.50 and last traded at $41.39. Approximately 183,121 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 730,307 shares. The stock had previously closed at $44.06.
Key Headlines Impacting Concentrix
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Strong cash generation and buybacks/dividend support valuation — Concentrix reported record operating cash flow ($807M FY2025) and adjusted free cash flow (~$626M), returned $258M to shareholders and repurchased shares in Q4; management targets $630–650M adjusted free cash flow for FY2026, which underpins the rally. Concentrix Reports Q4 and Fiscal Year 2025 Results (Quiver/Press)
- Positive Sentiment: Beat and forward guidance: revenue slightly ahead of expectations and management issued FY2026 non‑GAAP EPS guidance ($11.48–$12.07) plus Q1 guidance, signaling confidence in underlying operations and supporting upside to estimates. Concentrix Q4 Results / Slide Deck (Company)
- Positive Sentiment: Analyst support — Barrington Research reiterated an Outperform rating, which can amplify buying interest while the firm executes cash returns and guidance beats. Barrington Reiterates “Outperform”
- Neutral Sentiment: Longer‑term strategy: management is transforming the business toward GenAI, SaaS and technology-enabled services (moving beyond traditional call center work). This is strategically positive but execution/timing risk means immediate impact is uncertain. Seeking Alpha — Webhelp Write Off / Transformation
- Negative Sentiment: Large non‑cash goodwill impairment drove a GAAP operating and net loss — a $1.52B impairment pushed Q4 operating loss and FY2025 net loss, compressing GAAP margins and creating headline risk and valuation uncertainty despite healthy non‑GAAP results. That impairment is the primary negative driver for intraday volatility. GlobeNewswire — Q4/FY2025 Results
- Negative Sentiment: Margin pressure and lower non‑GAAP metrics year‑over‑year — non‑GAAP operating margin and adjusted EBITDA declined modestly y/y, and non‑GAAP EPS fell vs. prior year quarter, highlighting near‑term margin headwinds even as revenue grew. Yahoo Finance — Deep Dive on Margin Pressure
Analyst Ratings Changes
CNXC has been the subject of several research analyst reports. Robert W. Baird set a $52.00 price objective on shares of Concentrix in a report on Wednesday. Barrington Research reiterated an “outperform” rating and issued a $62.00 price objective on shares of Concentrix in a report on Monday. Canaccord Genuity Group reissued a “buy” rating and set a $80.00 target price on shares of Concentrix in a report on Tuesday, September 23rd. Weiss Ratings raised Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, January 8th. Finally, Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research report on Saturday, October 25th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $63.75.
Read Our Latest Analysis on Concentrix
Concentrix Price Performance
The company’s 50-day simple moving average is $38.50 and its 200 day simple moving average is $46.65. The company has a market capitalization of $2.58 billion, a P/E ratio of -1.99, a P/E/G ratio of 0.52 and a beta of 0.48. The company has a quick ratio of 1.56, a current ratio of 1.40 and a debt-to-equity ratio of 1.67.
Concentrix (NASDAQ:CNXC – Get Free Report) last released its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. The business had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. Concentrix’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the firm earned $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, sell-side analysts expect that Concentrix Corporation will post 10.11 earnings per share for the current fiscal year.
Concentrix Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 10th. Stockholders of record on Friday, January 30th will be issued a dividend of $0.36 per share. The ex-dividend date of this dividend is Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 3.5%. Concentrix’s dividend payout ratio is currently 30.44%.
Insider Buying and Selling at Concentrix
In related news, CEO Christopher A. Caldwell acquired 2,000 shares of the business’s stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average cost of $42.03 per share, with a total value of $84,060.00. Following the purchase, the chief executive officer owned 286,661 shares of the company’s stock, valued at approximately $12,048,361.83. The trade was a 0.70% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 3.20% of the company’s stock.
Hedge Funds Weigh In On Concentrix
Several hedge funds and other institutional investors have recently added to or reduced their stakes in CNXC. Huntington National Bank lifted its stake in shares of Concentrix by 6,011.1% in the third quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after buying an additional 541 shares during the last quarter. Quent Capital LLC acquired a new position in Concentrix in the 3rd quarter valued at $29,000. Larson Financial Group LLC raised its holdings in Concentrix by 224.9% in the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after acquiring an additional 479 shares during the period. Geneos Wealth Management Inc. lifted its position in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after acquiring an additional 522 shares during the last quarter. Finally, Rothschild Investment LLC increased its stake in shares of Concentrix by 14,980.0% in the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after purchasing an additional 749 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.
Concentrix Company Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.